Posted On: 11/28/2012 4:14:33 PM
Post# of 5789
MYGN. Myriad Genetics' Prolaris Test Predicts Biochemical Recurrence in Prostate Cancer Patients Following Radiation Therapy
http://finance.yahoo.com/news/myriad-genetics...00796.html
chart.
http://stockcharts.com/h-sc/ui?s=MYGN&p=D...7250769470

